Germany represents Europe’s largest medical cannabis market, with over 200,000 public prescriptions written in 2019.*
*German National Association of Statutory Health Insurance Funds
Germany represents Europe’s largest medical cannabis market, with over 200,000 public prescriptions written in 2019.*
*German National Association of Statutory Health Insurance Funds
  • Germany Overview
  • Materia in Germany
  • Partners
  • Products

Germany legalized medical cannabis in March 2017 and today is the largest medical cannabis market in Europe.

With a potential patient base of over 1 million patients, it stands to grow substantially over the next several years.

Materia aims to be one of Germany’s leading medical cannabis suppliers, with a commitment to availability, affordability and quality. Materia Germany was founded in June 2018 in Hamburg and supplies the pharmacies in Germany via well-established and competent fulfillment partners certified for pharmaceuticals and narcotic drugs.

Materia Deutschland GmbH is an approved pharmaceutical wholesaler holding the license section 52a of the German Medicinal Act (“AMG”) and the certification of Good Distribution Practice (“GDP”) granted by the Authority for Health and Consumer Protection of the Free and Hanseatic City Hamburg.

Further, Materia holds the permit for the trade of narcotic drugs as per section 3 of the German Narcotics Drugs Act (“BtMG”) and the License to distribute medical cannabis flowers that have undergone ionizing radiation treatment (“AmRadV”). 

Bedrocan

Materia is distributing medical cannabis in Germany which was cultivated by Bedrocan.
Bedrocan is one of World’s leading producers of standardised medicinal cannabis flos (the whole, dried flower).
They supply medicinal cannabis to the Office for Medicinal Cannabis (OMC) which exports the product to Germany and other countries.
The pharmaceutical quality of Bedrocan’s products meets the high standard that we set ourselves at Materia, delivering products with a consistent composition of cannabinoids and terpenes which is essential for the needs of patients.
For more information please head to our professional area.

BPI

Materia Deutschland GmbH is member of the Bundesverband der Pharmazeutischen Industrie e.V.

VCA

Materia is a proud industry partner to The Association of Cannabis Selling Pharmacies, whose membership consists of German pharmacies. 

EUMCA

Materia is a founding member of the European Medical Cannabis Association (EUMCA), which works with government, industry and patient groups to support the future development, growth and use of medical cannabis around Europe.

Materia currently offers a consistent supply of pharmaceutical-grade flower from producers like Bedrocan, and in 2020 will expand its portfolio to include a range of proprietary cannabis-based products manufactured in our EU-GMP certified facility in Malta.

Full details on our medical cannabis product suite and further information can be found in our section for professionals (belonging to the groups mentioned in section 10 of the German Drug Advertising Law “Heilmittelwerbegesetz”).

Go to our section for professionals.

0
83
m+

Population

/// With a population of over 83 million people, Germany is the largest federally legal medical cannabis market in Europe.

0
1
m+

Potential Patients

/// Current forecasts suggest Germany could see 1 million patients being prescribed medical cannabis products by 2024.

0
90
%

Public Coverage

/// Approximately 90% of the German population is covered under the national public healthcare system, meaning they would be reimbursed if they were to get a public prescription for medical cannabis.

0
20,000

Pharmacies

/// Germany has approximately 20,000 pharmacies, which could dispense medical cannabis to patients with a prescription. As of today fewer, than one tenth of them regularly stock cannabis.

Our Commitment to Quality

Materia is committed to becoming Germany’s medical cannabis supplier of choice, by delivering a best-in-class service across the entire value chain.

EU-GMP Imports

Via our EU-GMP certified facility in Malta and a vast network of import partners Materia is able to source, manufacture and import high quality cannabis products into Germany. 

Consistent & Affordable Supply

With a consistent supply of medical cannabis products Materia will demonstrate our commitment to patient access by reducing affordability barriers.

Robust Distribution

By leveraging the expertise of our partners in warehousing, logistics and fulfillment, we’ll ensure that our distribution supply chain is robust and fit for purpose.

Our Medical Cannabis Products

All medical cannabis products provided by Materia are EU-GMP certified with a range of different cannabinoid and terpene profiles ensuring safe and patient-specific therapy. Since the medicinal products distributed by Materia consist of cannabis dried flower, which is a prescription-accessed narcotic, we are unable to legally provide any specific public information about our medical cannabis products.

We are only allowed to provide further information on our products to health professionals. 

(In case that you are a health professional according to section 10 of the German Drug Advertising Law please register for our professional section). 

Professional Log In

For health professionals (according to section 10 of the German Drug Advertising Law “Heilmittelwerbegesetz”) interested to know the details of our medical cannabis product range, we have a dedicated restricted area (powered by DocCheck), where you can find the full product range, along with educational materials and the process for ordering online.

Log in here